 | Up a level |
Ambrodji, Alisa; Sadlon, Angélique; Amstutz, Ursula; Hoch, Dennis; Berger, Martin D.; Bastian, Sara; Offer, Steven M; Largiadèr, Carlo R. (2024). Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD). International journal of molecular sciences, 25(14) MDPI 10.3390/ijms25147599
Sadlon, Angélique (2024). In Silico Models to Validate Novel Blood-Based Biomarkers. Methods in molecular biology, 2785, pp. 321-344. Springer 10.1007/978-1-0716-3774-6_20
Sadlon, Angélique; Takousis, Petros; Ankli, Barbara; Alexopoulos, Panagiotis; Perneczky, Robert (2023). Association of chronic pain with biomarkers of neurodegeneration, microglial activation and inflammation in the CSF and impaired cognitive function. (In Press). Annals of neurology Wiley 10.1002/ana.26804
de With, M; Sadlon, A; Cecchin, E; Haufroid, V; Thomas, F; Joerger, M; van Schaik, R H N; Mathijssen, R H J; Largiadèr, C R (2023). Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe. ESMO open, 8(2), p. 101197. BMJ 10.1016/j.esmoop.2023.101197
Sadlon, Angélique; Ott, Martin; Kressig, Reto W (2023). Patients with geriatric syndromes and anti-amyloid therapies: lack of consideration? An exploratory analysis of the literature. Frontiers in aging neuroscience, 15(1256968), p. 1256968. Frontiers Research Foundation 10.3389/fnagi.2023.1256968
